Xspray Pharma AB (XSPRAY.XSTO) Financials

All currency values in kr millions unless otherwise noted

Scroll

Income Statement	DEC 2025	DEC 2024	DEC 2023	DEC 2022	DEC 2021
Revenues
Revenue	kr 0	kr 0	kr 0	kr 0	kr 0
Operating Income	-kr 159	-kr 283	-kr 181	-kr 131	-kr 97
Non-Operating
Net Interest Expense	-kr 17	-kr 2	-kr 1	-kr 0	-kr 0
Income Tax Expense	-kr 0	-kr 0	-kr 0	kr 0	kr 0
Net Income
Net Income	-kr 171	-kr 286	-kr 180	-kr 132	-kr 97
Per Share Data
Revenue Per Share	kr 0.00	kr 0.00	kr 0.00	kr 0.00	kr 0.00
EPS (Basic)	-kr 4.34	-kr 8.62	-kr 6.76	-kr 6.25	-kr 4.98
EPS (Diluted)	-kr 4.34	-kr 8.62	-kr 6.76	-kr 6.25	-kr 4.98
Shares Outstanding	39.5M	33.1M	26.6M	21.1M	19.4M

Related stocks: Biotechnology

NEWBRY.XSTONewbury Pharmaceuticals AB

NXTCL.XSTONextCell Pharma AB

KDEV.XSTOKDventures AB

BIOSGN.XSTOBiosergen AB

HEART.XSTOScandinavian Real Heart AB

2CUREX.XSTO2cureX AB

APOTEA.XSTOApotea AB

XVIVO.XSTOXVIVO Perfusion AB

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing XSPRAY.XSTO

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.